A detailed history of Israel Englander (Millennium Management LLC) transactions in Cure Vac N.V. stock. As of the latest transaction made, Millennium Management LLC holds 2,418,173 shares of CVAC stock, worth $6.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,418,173
Previous 2,872,919 15.83%
Holding current value
$6.94 Million
Previous $9.77 Million 27.21%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.74 - $3.79 $1.25 Million - $1.72 Million
-454,746 Reduced 15.83%
2,418,173 $7.11 Million
Q2 2024

Aug 14, 2024

BUY
$2.31 - $4.99 $258,324 - $558,026
111,829 Added 4.05%
2,872,919 $9.77 Million
Q1 2024

May 15, 2024

BUY
$2.94 - $4.34 $94,629 - $139,691
32,187 Added 1.18%
2,761,090 $8.37 Million
Q4 2023

Feb 14, 2024

BUY
$3.96 - $6.41 $3.35 Million - $5.42 Million
845,244 Added 44.87%
2,728,903 $11.5 Million
Q2 2023

Aug 14, 2023

BUY
$6.69 - $12.25 $624,518 - $1.14 Million
93,351 Added 5.21%
1,883,659 $19.6 Million
Q1 2023

May 15, 2023

BUY
$6.38 - $12.5 $5.9 Million - $11.6 Million
924,064 Added 106.67%
1,790,308 $12.5 Million
Q4 2022

Feb 14, 2023

BUY
$5.75 - $8.5 $1.9 Million - $2.81 Million
330,212 Added 61.6%
866,244 $5.22 Million
Q3 2022

Nov 14, 2022

BUY
$7.48 - $15.24 $13,695 - $27,904
1,831 Added 0.34%
536,032 $4.22 Million
Q2 2022

Aug 15, 2022

SELL
$13.18 - $19.41 $589,159 - $867,646
-44,701 Reduced 7.72%
534,201 $7.27 Million
Q1 2022

May 16, 2022

BUY
$14.73 - $35.25 $5.23 Million - $12.5 Million
355,287 Added 158.88%
578,902 $11.4 Million
Q4 2021

Feb 14, 2022

SELL
$33.72 - $48.22 $1.39 Million - $1.99 Million
-41,307 Reduced 15.59%
223,615 $7.67 Million
Q3 2021

Nov 15, 2021

BUY
$49.26 - $74.5 $11.4 Million - $17.3 Million
232,415 Added 714.97%
264,922 $14.5 Million
Q2 2021

Aug 16, 2021

SELL
$56.91 - $127.53 $2.32 Million - $5.19 Million
-40,728 Reduced 55.61%
32,507 $2.39 Million
Q1 2021

May 17, 2021

BUY
$79.79 - $126.29 $4.87 Million - $7.71 Million
61,030 Added 500.04%
73,235 $6.7 Million
Q4 2020

Feb 16, 2021

SELL
$46.76 - $136.27 $13.7 Million - $39.8 Million
-292,432 Reduced 95.99%
12,205 $989,000
Q3 2020

Nov 16, 2020

BUY
$43.8 - $77.2 $13.3 Million - $23.5 Million
304,637 New
304,637 $14.2 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.